Tumor vascularity on contrast-enhanced computed tomography as a predictive marker of metastatic potential for small nonfunctioning pancreatic neuroendocrine tumors
Author:
Kubo HidemasaORCID,
Ohgi KatsuhisaORCID,
Ohike NobuyukiORCID,
Norose Tomoko,
Ashida RyoORCID,
Yamada MihokoORCID,
Otsuka Shimpei,
Uesaka KatsuhikoORCID,
Sugiura TeiichiORCID
Reference37 articles.
1. Non-functional neuroendocrine carcinoma of the pancreas: incidence, tumor biology, and outcomes in 2,158 patients;Franko;J Gastrointest Surg,2010
2. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival;Halfdanarson;Ann Oncol,2008
3. Survival and incidence patterns of pancreatic neuroendocrine tumors over the last 2 decades: a SEER database analysis;Sonbol;Oncologist,2022
4. Clinicopathologic features and treatment trends of pancreatic neuroendocrine tumors: analysis of 9,821 patients;Bilimoria;J Gastrointest Surg,2007
5. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors;Rosenberg;Surgery,2016